The mesenchymal stromal/stem cells (MSCs) are known to secrete pleiotropic paracrine factors, contributing to tissue regeneration. This unique ability makes MSCs promising therapeutic tools for many diseases, including even those that were previously untreatable. Thus, the development of preconditioning approaches aimed at enhancing the paracrine function of MSCs attracts great interest. In the present work, we studied how the extracellular matrix, the essential part of the native tissue microenvironment, affects the secretory capacity of MSCs of various origins. The MSC-derived decellularized extracellular matrix (dECM), used as the cell culture substrate, triggered strong upregulation of FGF-2, MMP-1, HGF, GRO-α, GRO-β, CXCL-5, CXCL-6, IL-6, IL-8, G-CSF and MCP-1. Functional in vitro tests revealed that conditioned media derived from MSCs cultured on dECM significantly improved 3T3 fibroblast and HaCaT keratinocyte scratch wound healing, stimulated THP-1 monocyte migration and promoted capillary-like HUVEC-based tube formation compared to conditioned media from MSCs grown on plastic. In addition, we found that FAK inhibition promoted dECM-induced upregulation of paracrine factors, suggesting that this kinase participates in the MSCs’ paracrine response to dECM. Together, these findings demonstrate that dECM provides cues that considerably enhance the secretory function of MSCs. Thus, dECM usage as a cell culture substrate alone or in combination with a FAK inhibitor may be viewed as a novel MSC preconditioning technique.
1 October 2020 in Biochemical and Biophysical Research Communications
Mesenchymal stromal/stem cells (MSCs) are known to secrete a wide range of pleiotropic molecules promoting tissue repair and regeneration. Recent advances in cell sheet technology have demonstrated significant improvements in the regenerative capacity of MSCs within the sheet, retaining appropriate microenvironmental cues, and have suggested an instructing role of extracellular matrix (ECM). We previously found that the secretome of MSCs cultured on a decellularized MSC-derived ECM (dECM) was significantly enriched in dozens of cytokines, chemokines and growth factors compared to the secretome of MSCs grown on standard plastic dishes. The enriched secretome has been shown to have enhanced chemotactic and angiogenic properties, stimulate C2C12 myoblast proliferation and promote skeletal muscle regeneration in a murine in vivo model. Here, we report novel findings about dECM-induced changes in the miRNA profile of MSCs. We performed miRNA-seq and found 17 differentially expressed miRNAs in endometrial MSCs (MESCs) with miR-146a-5p being the most upregulated. Additionally, we investigated miR-146a-5p expression in MSCs of various origins after exposure to dECM, and found a correlation between miR-146a-5p upregulation and the general dECM-induced paracrine response. Furthermore, we demonstrated that miR-146a-5p mimics, transfected into C2C12 myoblasts, promoted their proliferation, suggesting a role for miR-146a-5p in myotropic effects mediated by the enriched secretome. These findings provide new insights into how ECM as a component of the MSC niche influences the secretory phenotype and modulates therapeutic properties of MSCs.
Decellularized extracellular matrices show а great promise as materials for tissue engineering and regenerative medicine. Recently, there has been an increasing interest in the use of cell-derived extracellular matrices (CD-ECMs). The present mini-review focuses on advantages and disadvantages of the CD-ECMs, describes the variety of approaches to modify the CD-ECMs and discusses the CD-ECMs application fields. In particular, CD-ECMs were shown to serve as cell culture substrate, as base for biocompatible scaffold production, as drug for cell-free therapy and as component of disease models.